• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒长度维持——一种替代机制。

Telomere length maintenance--an ALTernative mechanism.

作者信息

Royle N J, Foxon J, Jeyapalan J N, Mendez-Bermudez A, Novo C L, Williams J, Cotton V E

机构信息

Department of Genetics, University of Leicester, Leicester, UK.

出版信息

Cytogenet Genome Res. 2008;122(3-4):281-91. doi: 10.1159/000167814. Epub 2009 Jan 30.

DOI:10.1159/000167814
PMID:19188697
Abstract

The Alternative Lengthening of Telomeres (ALT) mechanism is utilised by approximately 10% of human tumours and a higher proportion of some types of sarcomas. ALT+ cell lines and tumours show heterogeneous telomere length, extra-chromosomal circular and linear telomeric DNA, ALT associated promyelocytic bodies (APBs), a high frequency of post-replication exchanges in telomeres (designated as telomere-sister chromatid exchanges, T-SCE) and high instability at a GC-rich minisatellite, MS32 (D1S8). It is clear that there is a link between the minisatellite instability and the mechanism that underpins ALT, however currently the nature of this relationship is uncertain. Single molecule analysis of telomeric DNA from ALT+ cell lines and tumours has revealed complex telomere mutations that have not been seen in cell lines or tumours that express telomerase. These complex telomere mutations cannot be explained by T-SCE but must arise by another inter-molecular process. The break-induced replication (BIR) model that may explain the observed high frequency of T-SCE and the presence of complex telomere mutations is reviewed.

摘要

端粒替代延长(ALT)机制在约10%的人类肿瘤以及更高比例的某些类型肉瘤中被利用。ALT阳性细胞系和肿瘤表现出端粒长度的异质性、染色体外环状和线性端粒DNA、ALT相关早幼粒细胞体(APB)、端粒复制后交换的高频率(称为端粒姐妹染色单体交换,T-SCE)以及富含GC的小卫星MS32(D1S8)处的高不稳定性。很明显,小卫星不稳定性与支撑ALT的机制之间存在联系,然而目前这种关系的本质尚不确定。对ALT阳性细胞系和肿瘤的端粒DNA进行的单分子分析揭示了复杂的端粒突变,这些突变在表达端粒酶的细胞系或肿瘤中未见。这些复杂的端粒突变无法用T-SCE来解释,而必定是由另一种分子间过程产生的。本文综述了可能解释观察到的T-SCE高频率以及复杂端粒突变存在的断裂诱导复制(BIR)模型。

相似文献

1
Telomere length maintenance--an ALTernative mechanism.端粒长度维持——一种替代机制。
Cytogenet Genome Res. 2008;122(3-4):281-91. doi: 10.1159/000167814. Epub 2009 Jan 30.
2
Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome.用于端粒维持的ALT途径的激活会影响人类基因组中的其他序列。
Hum Mol Genet. 2005 Jul 1;14(13):1785-94. doi: 10.1093/hmg/ddi185. Epub 2005 May 11.
3
Alternative lengthening of telomeres in mammalian cells.哺乳动物细胞中端粒的替代性延长
Oncogene. 2002 Jan 21;21(4):598-610. doi: 10.1038/sj.onc.1205058.
4
Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.在缺乏与端粒延长相关的早幼粒细胞白血病小体的替代延长的情况下,不依赖端粒酶的端粒长度维持。
Cancer Res. 2005 Apr 1;65(7):2722-9. doi: 10.1158/0008-5472.CAN-04-2881.
5
Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.人类肉瘤中端粒维持机制的不同模式:尤因肉瘤和骨肉瘤中端粒延长替代机制的患病率形成鲜明对比。
Genes Chromosomes Cancer. 2004 Oct;41(2):155-62. doi: 10.1002/gcc.20074.
6
Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.在缺乏与端粒替代延长(ALT)相关的早幼粒细胞白血病(PML)小体的脂肪肉瘤中端粒替代延长的证据。
Int J Cancer. 2008 Jun 1;122(11):2414-21. doi: 10.1002/ijc.23412.
7
Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.端粒酶和替代端粒延长非依赖性端粒稳定在一种转移来源的人非小细胞肺癌细胞系中的作用:异位hTERT的影响
Cancer Res. 2006 Apr 1;66(7):3584-92. doi: 10.1158/0008-5472.CAN-05-2839.
8
A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.一种用于检测肿瘤中端粒替代延长的可靠检测方法显示了端粒替代延长在肉瘤和星形细胞瘤中的重要性。
Clin Cancer Res. 2005 Jan 1;11(1):217-25.
9
Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells.人类端粒酶替代(ALT)细胞中端粒间和端粒内突变的分子特征分析
Nat Genet. 2002 Mar;30(3):301-5. doi: 10.1038/ng834. Epub 2002 Feb 4.
10
Telomeres and telomerase in sarcomas.肉瘤中的端粒与端粒酶
Anticancer Res. 2009 Oct;29(10):3833-6.

引用本文的文献

1
Inhibition of p53 and ATRX increases telomeric recombination in primary fibroblasts.抑制 p53 和 ATRX 可增加原代成纤维细胞中端粒的重组。
FEBS Open Bio. 2023 Sep;13(9):1683-1698. doi: 10.1002/2211-5463.13680. Epub 2023 Aug 3.
2
Telomeric Repeat-Binding Factor Homologs in : New Clues for Telomeric Research.端粒重复结合因子同源物在端粒研究中的新线索。
Front Cell Infect Microbiol. 2018 Oct 2;8:341. doi: 10.3389/fcimb.2018.00341. eCollection 2018.
3
The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype.
ATRX在端粒替代延长(ALT)表型中的作用。
Genes (Basel). 2016 Sep 19;7(9):66. doi: 10.3390/genes7090066.
4
Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.肉瘤中端粒替代延长表型及 ATRX 表达缺失的综合筛查。
Mod Pathol. 2015 Dec;28(12):1545-54. doi: 10.1038/modpathol.2015.114. Epub 2015 Oct 2.
5
Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas.端粒的替代性延长和ATRX缺失是多形性和去分化脂肪肉瘤中的常见现象。
Mod Pathol. 2015 Aug;28(8):1064-73. doi: 10.1038/modpathol.2015.67. Epub 2015 May 29.
6
Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein-Barr virus.端粒功能障碍和 Epstein-Barr 病毒感染的 B 淋巴细胞中端粒的非经典延长激活。
Oncogene. 2013 Dec 5;32(49):5522-30. doi: 10.1038/onc.2013.189. Epub 2013 May 27.
7
HPV16 E7 protein and hTERT proteins defective for telomere maintenance cooperate to immortalize human keratinocytes.HPV16 E7 蛋白和 hTERT 蛋白缺陷导致端粒维持合作,使人类角质形成细胞永生化。
PLoS Pathog. 2013;9(4):e1003284. doi: 10.1371/journal.ppat.1003284. Epub 2013 Apr 4.
8
The genetics of osteosarcoma.骨肉瘤的遗传学
Sarcoma. 2012;2012:627254. doi: 10.1155/2012/627254. Epub 2012 May 20.
9
PML body meets telomere: the beginning of an ALTernate ending?PML 体与端粒相遇:非经典端粒末端连接的开始?
Nucleus. 2012 May-Jun;3(3):263-75. doi: 10.4161/nucl.20326. Epub 2012 May 1.
10
Telomerase-independent paths to immortality in predictable cancer subtypes.可预测癌症亚型中不依赖端粒酶的永生途径。
J Cancer. 2012;3:67-82. doi: 10.7150/jca.3965. Epub 2012 Jan 31.